Cancro dell’endometrio (tumore dell’endometrio)

Bibliografia

Quali fonti bibliografiche considerare per il Cancro dell’endometrio (tumore dell’endometrio)?

Le informazioni contenute nella ricerca Pharmamedix dedicata al cancro dell’endometrio (tumore dell’endometrio) sono state analizzate con riferimento alle seguenti fonti.

1. Agnew H. et al., Cochrane Database Syst. Rev., 2023, 3 (3), CD012513.


2. Anca-Stanciu M.B. et al., J. Clin Med., 2025, 14 (4), 1385.


3. Baker-Rand H., Kitson S.J., Cancers (Basel), 2024, 16 (5), 1028.


4. Berek J.S. et al., Int. J. Gynaecol. Obstet., 2023, 162 (2), 383.


5. Boeckstaens S. et al., Heliyon, 2020, 6 (11), e05372.


6. Bogani G. et al., Eur. J. Surg. Oncol., 2026, 52 (4), 111453.


7. Bray F. et al., CA Cancer J. Clin., 2024, 74 (3), 229.


8. Bryce C. et al., Am. Fam. Physician, 2025, 111 (6), 526.


9. Clark C. et al., Cancers (Basel), 2025, 17 (7), 1145.


10. Clarke M.A. et al., JAMA Intern. Med., 2018, 178 (9), 1210.


11. Collaborative Group on Epidemiological Studies on Endometrial Cancer, Lancet Oncol., 2015, 16 (9), 1061.


12. Concin N. et al., Virchows Arch., 2021, 478 (2), 153.


13. Concin N. et al., Lancet Oncol., 2025, 26 (8), e423.


14. De Oliveira H.L. et al., Toxicol. In Vitro, 2026, 112, 106194.


15. Dos Santos A.P. et al., Homeopathy, 2021, 110 (2), 76.


16. Dreisler E. et al., Maturitas, 2024, 184, 107944.


17. El Khoury D. et al., Int. J. Womens Health, 2019, 11, 249.


18. Eskander R.N. et al., NEJM, 2023, 388 (23), 2159.


19. Fader A.N. et al., Clin. Cancer Res., 2020, 26 (15), 3928.


20. Frenkel M., Altern. Ther. Health Med., 2010, 16 (3), 12.


21. Frenkel M., Curr. Oncol. Rep., 2015, 17 (9), 43.


22. Ghadirzadeh B. et al., Acta Diabetol., 2026, 63 (8), 1321.


23. Ghanavati M. et al., Cancer Rep. (Hoboken), 2023, 6 (4), e1806.


24. Harajka A. et al., Acta Obstet. Gynecol. Scand., 2025, 104 (4), 591.


25. Hooks O. et al., Curr. Oncol., 2025, 32 (12), 672.


26. Jahanbakhshi F. et al., Cancer Cell Int., 2021, 21 (1), 120.


27. Johnson J.E. et al., Oncol. Lett., 2023, 25 (4), 168.


28. Kaneuchi M. et al., Int. J. Oncol., 2003, 22 (1), 159.


29. Kassab S. et al., Cochrane Database Syst. Rev., 2009, 2009 (2), CD004845.


30. Kitson S.J. et al., Cancer Prev. Res. (Phila), 2022, 15 (9), 605.


31. Kluk A. et al., Int. J. Mol. Sci., 2026, 27 (3), 1304.


32. Konstantakopoulos N. et al., Mol. Carcinog., 2006, 45 (10), 752.


33. Koskas M. et al., Int. J. Gynaecol. Obstet., 2025, 171 Suppl 1 (Suppl 1), 60.


34. Labudda M. et al., Biochimie, 2026, 244, 147.


35. León-Castillo A. et al., J. Clin. Oncol., 2020, 38 (29), 3388.


36. Lim N. et al., Int. J. Gynecol. Cancer, 2022. 32 (5), 646.


37. MacKintosh M.L., Crosbie E.J., Curr. Oncol. Rep., 2018, 20 (12), 101.


38. Madár i. et al., Cancers (Basel), 2024, 16 (5), 907.


39. Makker V. et al., NEJM, 2022, 386 (5), 437.


40. Malloy K.M. et al., Am. J. Transl. Res., 2018, 10 (3), 784.


41. Masci Walter, Omeopatia - Tradizione e attualità, 2003, Tecniche Nuove.


42. Marchetti C. et al., Eur. J. Cancer, 2026, 240, 116739.


43. Matias-Guiu X. Et al., Eur. J. Cancer, 2024, 213, 115115.


44. Milazzo S. et al., Eur. J. Cancer, 2006, 42 (3), 282.


45. Miller D.S. et al., J. Clin. Oncol., 2020, 38 (33), 3841.


46. Mirza M.R. et al., NEJM, 2023, 388 (23), 2154.


47. Oaknin A. et al., Ann. Oncol., 2022, 33 (9), 860.


48. Padilla-Iserte P. et al., Cancers (Basel), 2026, 18 (11), 1709.


49. Pennant M.E. et al., BJOG, 2017, 124 (3), 404.


50. Pérez Ramírez S. et al., Clin. Transl. Oncol., 2025, 27 (12), 4268.


51. Poonyachoti S., Deachapunya C., J. Med. Assoc. Thai., 2012, 95 Suppl. 12, S105.


52. Post C.C.B. et al., Lancet Oncol., 2025, 26 (10), 1370.


53. Raglan O. et al., Int. J. Cancer, 2019, 145 (7), 1719.


54. Rodolakis A. et al., Hum. Reprod. Open, 2023, 2023 (1), hoac057.


55. Ruffini M.L. et al., Int. J. Gynaecol. Obstet., 2025, 171 (2), 613.


56. Ryan N.A.J., et al., Genet. Med., 2019, 21 (10), 2167.


57. Rodríguez-Palacios D.A. et al., Int. J. Environ. Res. Public Health, 2022, 19 (7), 3789.


58. Sakna N.A. et al., BMJ Open, 2023, 13 (6), e072124.


59. Saed L. et al., BMC Cancer, 2019, 19 (1), 527.


60. Kaneuchi M. et al., Int. J. Oncol., 2003, 23 (4), 1167.


61. Singh A. et al., Drug Discov. Today, 2022, 27 (3), 900.


62. Sjögren L.L. et al., Maturitas., 2016, 91, 25.


63. Slomovitz B.M. et al., Gynecol. Oncol., 2022, 164 (3), 481.


64. Suzuki Y. et al., Am. J. Obstet. Gynecol., 2024, 231 (6), 599.


65. Tangelloju A. et al., Curr. Drug Targets, 2022, 23 (13), 1252.


66. Tempfer C.B. et al., Cancers (Basel), 2020, 12 (8), 2195.


67. van Weelden W.J. et al., BJOG, 2023, 130 (2), 143.


68. Vitale S.G. et al., Minim. Invasive Ther. Allied. Technol., 2025, 34 (2), 114.


69. Wagenknecht A. et al., J. Cancer Res. Clin. Oncol., 2023, 149 (5), 1785.


70. Wagner V.M., Backes F.J., Cancers (Basel), 2023, 15 (6), 1799.


71. Wang Y., Zhang S., Biomed. Pharmacother., 2018, 103, 1287.


72. World Health Organisation - WHO, 1993, Research guidelines for evaluating the safety and efficacy of herbal medicines.


73. Wu H-C. et al., Curr. Issues Mol. Biol., 2026, 48 (4), 408.


74. Xu H. et al., Cell Physiol. Biochem., 2018, 48 (2), 569.


75. Yang Q. et al., Front. Pharmacol., 2024, 15, 1417532.


76. Zhang Y. et al., Fitoterapia, 2026, 188, 106980.


77. Zhu P. et al., Eur. J. Obstet. Gynecol. Reprod. Biol., 2025, 310, 113997.


78. Zola P. et al., J. Clin. Oncol., 2022, 40 (33), 3817.